InVivoMAb anti-mouse IL-6R
BE0047
ApplicationsNeutralisation/Blocking
Product group Antibodies
Overview
- SupplierBio X Cell
- Product NameInVivoMAb anti-mouse IL-6R
- Delivery Days Customer7
- ApplicationsNeutralisation/Blocking
- CertificationResearch Use Only
- ClonalityMonoclonal
- Clone ID15A7
- Concentration4-11 mg/ml
- Estimated Purity>95%
- HostRat
- IsotypeIgG2b
- Storage Instruction2°C to 8°C
- UNSPSC12352203
References
- Tsukamoto H, Senju S, Matsumura K, et al. IL-6-mediated environmental conditioning of defective Th1 differentiation dampens antitumour immune responses in old age. Nat Commun. 2015,6:6702. doi: 10.1038/ncomms7702Read this paper
- Barber DL, Andrade BB, McBerry C, et al. Role of IL-6 in Mycobacterium avium--associated immune reconstitution inflammatory syndrome. J Immunol. 2014,192(2):676-82. doi: 10.4049/jimmunol.1301004Read this paper
- Pham D, Walline CC, Hollister K, et al. The transcription factor Twist1 limits T helper 17 and T follicular helper cell development by repressing the gene encoding the interleukin-6 receptor α chain. J Biol Chem. 2013,288(38):27423-27433. doi: 10.1074/jbc.M113.497248Read this paper
- Markey KA, Koyama M, Kuns RD, et al. Immune insufficiency during GVHD is due to defective antigen presentation within dendritic cell subsets. Blood. 2012,119(24):5918-30. doi: 10.1182/blood-2011-12-398164Read this paper
- Piconese S, Gri G, Tripodo C, et al. Mast cells counteract regulatory T-cell suppression through interleukin-6 and OX40/OX40L axis toward Th17-cell differentiation. Blood. 2009,114(13):2639-48. doi: 10.1182/blood-2009-05-220004Read this paper
